Join Dr. Laila Tabatabai for an engaging discussion on the evolving landscape of fracture risk assessment and management strategies in postmenopausal osteoporosis. 

In this educational session, attendees will explore fracture risk beyond bone mineral density and how clinical risk factors play a critical role in identifying patients at very high fracture risk. Attendees will also review emerging approaches to diagnosis and risk stratification.

Dr. Tabatabai will discuss the importance of early and proactive intervention, current guideline recommendations for the management of osteoporosis, and the rationale behind treatment sequencing strategies designed to rapidly reduce fracture risk. Through practical insights and real-world clinical perspectives, this session will help clinicians better identify very high-risk patients and apply evidence-based management strategies.

This presentation is sponsored by Amgen. There is no continuing education credit available for attending this presentation.